Literature DB >> 1789816

Clinical considerations regarding treatment of hypercholesterolemia in the elderly.

D W Bilheimer1.   

Abstract

Therapy for hypercholesterolemia has been shown to reduce the risk for coronary heart disease in middle-aged men. Current guidelines for detecting and treating hypercholesterolemia in adults render large numbers of elderly patients eligible for medical intervention. The elderly are a heterogeneous group of individuals who differ widely in their ability to function physically, behaviorally, cognitively and emotionally. Not all elderly patients qualify for cholesterol-lowering therapy. Decisions regarding diagnostic and therapeutic interventions should be based on the physiological age of the patient rather than the chronological age, and on the presence and severity of concomitant disease, mental status and cognitive ability, as well as on the patient's expectations from medical care. Suggestions for dietary therapy and drug therapy in the elderly are provided. The objectives and potential benefits of therapy are described. Based on the information currently available, it is concluded that the elderly are likely to benefit from cardiovascular risk factor modification and should not be denied cholesterol-lowering therapy simply on the basis of their chronological age.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1789816     DOI: 10.1016/0021-9150(91)90205-h

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  3 in total

Review 1.  HMG-CoA reductase inhibitor use in the aged. A review of clinical experience.

Authors:  C J Lintott; R S Scott
Journal:  Drugs Aging       Date:  1992 Nov-Dec       Impact factor: 3.923

2.  Longitudinal trajectories of cholesterol from midlife through late life according to apolipoprotein E allele status.

Authors:  Brian Downer; Steven Estus; Yuriko Katsumata; David W Fardo
Journal:  Int J Environ Res Public Health       Date:  2014-10-16       Impact factor: 4.614

3.  Comparison of the efficacy and tolerability of policosanol with atorvastatin in elderly patients with type II hypercholesterolaemia.

Authors:  Gladys Castaño; Rosa Mas; Lilia Fernández; José Illnait; Meylin Mesa; Estrella Alvarez; Magnolia Lezcay
Journal:  Drugs Aging       Date:  2003       Impact factor: 4.271

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.